Neuroprotective effect of low-dose paracetamol treatment against cognitive dysfunction in d-galactose-induced aging mice

BACKGROUND: Aging is closely associated to several deleterious conditions and cognitive impairment. Administration of low-dose paracetamol (APAP) has previously been reported to improve cognitive performance in both human and animal studies. However, the altered cognitive effects of low-dose APAP tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalert, Laddawan, Maneesri le-Grand, Supang, Techarang, Tachpon, Huntula, Soontaraporn, Punsawad, Chuchard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586893/
https://www.ncbi.nlm.nih.gov/pubmed/36281406
http://dx.doi.org/10.1016/j.heliyon.2022.e11108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586893/
https://www.ncbi.nlm.nih.gov/pubmed/36281406
http://dx.doi.org/10.1016/j.heliyon.2022.e11108

Ejemplares similares